US Broker Ratings

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 33% Upside Amidst Market Challenges

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a notable player in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing. With a market capitalization of..

Verona Pharma plc (VRNA) Stock Analysis: Navigating Growth in the Biotech Landscape with a $9.09 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA), a UK-based biopharmaceutical firm, stands out in the healthcare sector with a market capitalization of $9.09 billion. Specializing in developing therapies for respiratory diseases, Verona..

Bruker Corporation (BRKR) Stock Analysis: Potential Upside of 25.62% Amidst Diverse Healthcare Innovations

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector and a leader in the medical devices industry, is catching the attention of investors with its promising growth potential...

Quest Diagnostics (DGX) Stock Analysis: Strong Performance with Limited Upside in Diagnostics & Research Sector

Quest Diagnostics Incorporated, trading under the ticker symbol DGX, is a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry. Headquartered in Secaucus, New Jersey, Quest..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare’s Dynamic Landscape with a 16.6% Revenue Growth

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, is capturing the attention of investors with its robust revenue growth and strategic positioning within the United States’ healthcare..

Insulet Corporation (PODD) Stock Analysis: Riding High on a 13.84% Potential Upside

Insulet Corporation (NASDAQ: PODD) continues to be a compelling player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $22.43 billion, Insulet has carved..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring Growth Potential in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN) is a key player in the healthcare sector, particularly within the medical devices industry. With a substantial market capitalization of $15.4 billion, the..

UnitedHealth Group (UNH) Stock Analysis: Healthcare Giant with a 4.33% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable player in the healthcare sector, boasting a market capitalization of $322.96 billion. This sprawling healthcare titan operates through its prominent segments:..

Masimo Corporation (MASI) Stock Analysis: Exploring a 27.79% Potential Upside

Investors with an eye on the healthcare sector may want to consider Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices industry. With a market capitalization of $7.97..

Exelixis, Inc. (EXEL) Stock Analysis: Examining a 12.77% Potential Upside in Biotechnology

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology sector with a market capitalization of $10.57 billion, reflecting its established presence in the healthcare industry. Specializing in the discovery, development,..

Veeva Systems Inc. (VEEV) Stock Analysis: Assessing Growth Potential with a 13% Upside

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software solutions for the life sciences industry, is capturing investor interest with a potential upside of 13%, as indicated by the..

Incyte Corporation (INCY): Investor Outlook on Growth and Market Position

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, presents an intriguing case for investors focused on the healthcare industry. With a market capitalization of $17.1 billion, Incyte..

Elanco Animal Health (ELAN) Investor Outlook: Navigating Growth in the Animal Health Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the niche of drug manufacturers focusing on specialty and generic products. With a..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Analyzing the 16% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a key player in the biotechnology sector, has been capturing attention with its promising clinical-stage developments. Based in the United Kingdom, this biopharmaceutical company is..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 26.49% Upside Potential Awaits Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, specializes in designing and manufacturing single-use medical products. The company, which operates through its Cardiovascular and Endoscopy..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Robust Healthcare Giant with a Marginal Potential Upside

HCA Healthcare, Inc. (NYSE: HCA) stands as a behemoth in the healthcare sector, boasting a formidable market capitalization of $99.72 billion. Headquartered in Nashville, Tennessee, HCA operates a vast network..

BeOne Medicines Ltd. (ONC) Investor Outlook: Key Insights on a 20.86% Potential Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its robust pipeline of oncology treatments. Headquartered in Basel, Switzerland, this..

Novo Nordisk A/S (NVO): Investor Outlook with 16% Upside Potential Amid Strong Revenue Growth

Novo Nordisk A/S (NYSE: NVO) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Bagsvaerd, Denmark, the company commands an impressive market..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring the 12.55% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, presents a compelling investment opportunity with a potential upside of 12.55%. With a diverse portfolio centered around the..

Exact Sciences Corporation (EXAS) Stock Analysis: A 12.95% Upside with Strong Buy Ratings

Exact Sciences Corporation (NASDAQ: EXAS) is drawing significant attention from investors, especially in the healthcare sector, with its promising diagnostic and screening products for cancer detection. As a major player..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds